Latest Vietnam News

Donaco International Limited has entered a binding acquisition scheme with On Nut Road Limited at A$0.045 per share, deemed fair and reasonable by an independent expert. The Board unanimously recommends shareholder approval ahead of the August 2025 vote.

Blackstone Minerals has completed its acquisition of IDM International, gaining full control of the Mankayan copper-gold project in the Philippines. The scheme of arrangement is now effective, marking a significant expansion of Blackstone’s Southeast Asia portfolio.

Simble Solutions Limited has secured $527,375 through a strategic capital raising and appointed Faldi Ismail as its new Non-Executive Chairman, signaling a renewed focus on growth and innovation including blockchain investments.

Blackstone Minerals has received Supreme Court approval to acquire IDM International, gaining control of the significant Mankayan copper-gold project in the Philippines. The scheme is set to become effective mid-June, marking a strategic expansion for Blackstone in Southeast Asia's critical minerals sector.

IDM International shareholders have overwhelmingly approved Blackstone Minerals’ acquisition via a scheme of arrangement, setting the stage for a transformative merger in the copper-gold mining sector.

EZZ Life Science has inked a three-year distribution deal with ROFA Enterprises, marking a significant step into Southeast Asia’s booming health market. The agreement guarantees at least A$21 million in sales across Thailand, Vietnam, and Singapore.

Donaco International has updated the timeline for its acquisition by On Nut Road Limited, pushing key dates into August due to valuation and legal review delays. Shareholders await the next steps in this protracted takeover process.

Papyrus Australia has secured a pivotal contract with UniSA to establish a Rapid Prototyping and R&D facility, advancing its sustainable packaging technology and commercial production plans.

TruScreen Group Limited has announced a capital raising initiative involving Placement and Share Purchase Plan (SPP) Options, aiming to secure approximately NZ$3 million to fund strategic growth and working capital needs. The offer, subject to shareholder approval, includes up to 80.9 million Placement Options and 55.5 million SPP Options exercisable at A$0.02.

TruScreen Ordinary Shares Group Limited has announced a combined share purchase plan and placement to raise approximately NZD 1.78 million, aiming to accelerate its international expansion and cervical cancer screening initiatives.

TruScreen Group Limited has launched a NZ$1.22 million Share Purchase Plan offering discounted shares to eligible investors, aiming to fuel growth in key international markets and public health initiatives.

TruScreen Group Limited forecasts a robust 64% increase in FY26 sales, driven by strategic market expansions and new distribution agreements. The company’s AI-enabled cervical cancer screening technology is gaining traction across emerging markets.